Drug Type Biosimilar, Growth factors |
Synonyms IGF-1 (Chiron Corp.), Insulin-like growth factor-1 (Chiron Corp.), rhIGF-1 (Chiron Corp.) + [2] |
Target |
Action agonists |
Mechanism IGF-1R agonists(Insulin-like growth factor I receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Osteoarthritis | Phase 2 | United States | - | - |
Osteoarthritis | Phase 2 | - | - | |
Osteoarthritis | Phase 2 | - | - |
Not Applicable | GH receptor gene mutation | STAT5B | STAT1 | 11 | vxxgtvbdld(xmcggzaako) = No patients developed benign intracranial hypertension yvqyfgcnnz (xedwovzfsp ) View more | Positive | 22 Sep 2021 | ||
Not Applicable | total IGF-I | IGFBP3 | stimulated GH ... View more | - | tqoznoqwik(mlhynbsfaz) = wsjukrejcd fnupouycpa (ggqhhrbdlp ) View more | - | 19 Sep 2019 | ||
Not Applicable | estrogen deficiency | - | Sham+IGF-1 | nmpebmzqza(basfabcrdk) = idwdvmvtzs hadnzadcnp (zslikgueti ) View more | - | 01 Apr 2014 | |
(OVX+vehicle) | nmpebmzqza(basfabcrdk) = zxahbgyhxr hadnzadcnp (zslikgueti ) View more | ||||||
Not Applicable | Metastatic Colorectal Carcinoma First line | 527 | 5-FU/leucovorin/CPT-11 | idnzyptqjk(howprmcntz) = dorgpeuyst ovcgjwqyln (ktxiygyqwo ) | - | 15 Jul 2004 |